is bpc 157 intramuscular bpc-157 injection method subcutaneous or vs BPC-157 Injection vs Oral Peptide: Injectable, Oral, and Nasal BPC-157 Peptide The Hidden Risks of BPC‑157:

Can BPC-157 cause cancer

Unlike receptor-defined peptide systems such as GLP-1 receptor agonists, amylin analogs, or growth-hormone / GHRH-related receptor-targeted peptides, BPC-157s reported effects have been attributed in published research to modulation of several intersecting signaling pathways without a definitively established primary molecular target

For those with serious anemia, this medication may rarely cause hypokalemia (low potassium)

[PMID: 3944259] PubMed record related to this compound for laboratory literature review

Neurological Issues : This includes numbness or tingling in the hands and feet, as well as balance issues